GlassScriptPhysician profile
Dennis M Cassidy
NPI 1649272006
$2,689.86
in general payments reported to CMS, 2019-2025
24 companies · $647 in 2025
The $647 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $427 · 2020: $132 · 2021: $245 · 2022: $333 · 2023: $553 · 2024: $351 · 2025: $647.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,552.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,551.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $590.15 | 2021-2023 | Micra, Cobalt Dr Mri Surescan, Resolute Onyx |
| Abbott Laboratories | $264.14 | 2019-2020 | |
| Cvrx, INC. | $227.46 | 2025 | Barostim Neo System |
| Pfizer INC. | $221.65 | 2022-2025 | |
| Biotronik INC. | $173.89 | 2019 | |
| Boston Scientific Corporation | $169.00 | 2021-2023 | Watchman Access System |
| Heartflow, INC. | $148.52 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $133.94 | 2023-2024 | Lifevest |
| Medtronic Vascular, INC. | $121.25 | 2019 | |
| Janssen Pharmaceuticals, INC | $118.56 | 2022-2024 | Xarelto |
| Biosense Webster, INC. | $110.42 | 2023-2025 | Carto 3 |
| Novartis Pharmaceuticals Corporation | $86.39 | 2023-2025 | |
| Amgen INC. | $52.00 | 2024-2025 | Repatha, Repatha |
| Impulse Dynamics (USA) INC. | $45.73 | 2024 | Optimizer |
| Cardiovascular Systems INC. | $37.75 | 2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $31.35 | 2025 | Onpattro |
| Cleerly, INC. | $29.08 | 2025 | Cleerly Labs, Cleerly Ischemia |
| Abiomed | $25.40 | 2022 | |
| Acumed LLC | $24.67 | 2025 | Ribloc, Biobridge |
| E.R. Squibb & Sons, L.L.C. | $21.89 | 2025 | Eliquis |
| Kerecis Limited | $15.08 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Baxter Healthcare | $14.70 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
| Altathera Pharmaceuticals LLC | $13.73 | 2023 | Sotalol Hydrochloride |
| Sanofi-Aventis U.S. LLC | $13.11 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dennis Cassidy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.